DIDRONEL Drug Patent Profile

✉ Email this page to a colleague

When do Didronel patents expire, and when can generic versions of Didronel launch?

Didronel is a drug marketed by Mgi Pharma Inc and Apil and is included in two NDAs.

The generic ingredient in DIDRONEL is etidronate disodium. There are four drug master file entries for this compound. Additional details are available on the etidronate disodium profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DIDRONEL?
What are the global sales for DIDRONEL?
What is Average Wholesale Price for DIDRONEL?

Summary for DIDRONEL

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	63
Clinical Trials:	2
DailyMed Link:	DIDRONEL at DailyMed

Drug patent expirations by year for DIDRONEL

Recent Clinical Trials for DIDRONEL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 3
Eisai Co., Ltd.	Phase 3

See all DIDRONEL clinical trials

US Patents and Regulatory Information for DIDRONEL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mgi Pharma Inc	DIDRONEL	etidronate disodium	INJECTABLE;INJECTION	019545-001	Apr 20, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apil	DIDRONEL	etidronate disodium	TABLET;ORAL	017831-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apil	DIDRONEL	etidronate disodium	TABLET;ORAL	017831-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DIDRONEL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apil	DIDRONEL	etidronate disodium	TABLET;ORAL	017831-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Apil	DIDRONEL	etidronate disodium	TABLET;ORAL	017831-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Mgi Pharma Inc	DIDRONEL	etidronate disodium	INJECTABLE;INJECTION	019545-001	Apr 20, 1987	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DIDRONEL

See the table below for patents covering DIDRONEL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	1502813	Nouveau dérivé de la podophyllotoxine et sa préparation	⤷ Sign Up
Finland	44411		⤷ Sign Up
United Kingdom	1145909		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for DIDRONEL

Recent Clinical Trials for DIDRONEL

Make Better Decisions: Try a trial or see plans & pricing